Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Micsi
AddedMar 17, 2024
UpdatedJul 2, 2026
Micsi

Micsi

Seed

Revolutionizing MRI imaging with AI software for faster scans and higher resolution.

Founded
2018
Accelerator
Y Combinator logoY CombinatorS23
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize MRI imaging, Micsi aims to enhance diagnostic capabilities through advanced AI software. The company's core vision is to transform MRI technology into a truly quantitative instrument, providing highly reproducible data for more accurate diagnoses. Micsi's flagship product doubles the resolution and halves the scan time of MRI procedures, significantly improving capacity and patient throughput in imaging centers. This innovation not only promises to save countless lives but also offers substantial financial benefits, potentially generating an additional $2 million of revenue per MRI scanner.

Micsi has garnered attention from notable investors and industry experts who recognize the transformative potential of its technology. The company has achieved significant milestones, including successful pilot programs and partnerships with leading medical institutions. By leveraging cutting-edge AI, Micsi is setting new standards in medical imaging, making a profound impact on both patient care and the operational efficiency of healthcare providers.

Micsi - Similar Companies

HeartVista logo

HeartVista

Darmiyan logo

Darmiyan

darmiyan.com

Subtle Medical logo

Subtle Medical

subtlemedical.com

Caire Health logo

Caire Health

cairehealth.com

Alpha-Mri logo

Alpha-Mri

SpinTech logo

SpinTech

Imaginostics logo

Imaginostics

imaginostics.com

DeepRadiology logo

DeepRadiology

deepradiology.com

Moichor logo

Moichor

moichor.com

Turing Medical logo

Turing Medical

turingmedical.com

Scanbase logo

Scanbase

scanbase.com

Segmed logo

Segmed

segmed.ai

InVision Medical Technology logo

InVision Medical Technology

Mrimath logo

Mrimath

RAD AI logo

RAD AI

radai.com

Micsi - Quick Facts

Who are Micsi's competitors?

Companies similar to Micsi include HeartVista, Darmiyan, Subtle Medical and Caire Health.

When was Micsi founded?

Micsi was founded in 2018.

When was Micsi's last funding round?

Micsi's most recent funding round was for $500k (USD) in June 2023.

How much has Micsi raised to-date?

As of Jun 1, 2023, Micsi has raised a total of $500k (USD).

How many employees does Micsi have?

Micsi has 2 employees as of Sep 1, 2023.

Micsi - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • AI Software
  • MRI Software
Tags
  • Healthcare
  • Healthtech
  • SaaS